Streptomyces clavuligerus produces penicillin N, several cephalosporins and the /3-lactamase inhibitor clavulanic acid. The detection, isolation and properties of further metabolites of this culture, MM 21801 and MM 19290, are described. MM 21801 was identified as the antibiotic holomycin. MM 19290 was shown to be related to tunicamycin, an antibiotic complex obtained from cultures of Streptomyces lysosuperificus.
Streptomyces clavuligerus ATCC 27064 (NRRL 3585) was first described as a producer of penicillin N and of a number of antibiotics structurally related to cephalosporin C, namely the 3-carbamoyloxymethyl analogue and the 7-methoxy derivative of the latter (cephamycin C), and deacetoxycephalosporin C"22,3). More recently, a potent inhibitor of /3-lactamase, clavulanic acid, was isolated from Streptomyces clavuligerus''", and shown to be a novel fused /3-lactam.1) The culture has since also been found to produce a series of clavams with antifungal activity.') We report here the detection and isolation of further antibiotics from Streptomyces clavuligerus, which have been identified as holomycin (MM 21801) and a complex (MM 19290) related to tunicamycin.
Detection Methods
In order to detect the presence of substances with antibacterial activity in cultures of Streptomyces clavuligerus, a biochromatographic procedure was used. Samples of the culture filtrate were applied to 1-cm-wide paper strips of Whatman Grade 1, and descending chromatography carried out at 4°C. The dried strips were contacted with agar plates seeded with Bacillus subtilis ATCC 6633, Sarcina lutea NCTC 8340 or Klebsiella pneumoniae ATCC 29665 as test organisms. In addition, a special bioautographic method, in which the agar contained both Klebsiella pneumoniae ATCC 29665 and benzylpenicillin, was used to locate the /3-lactamase inhibitor clavulanic acid."
MM 21801
Fermentation and Isolation Mycelium and spores from an agar slope of a mutant strain of Streptomyces clavuligerus , designated ITI, produced by far UV irradiation of the parent culture, were used to inoculate 50O-m1 flasks containing 100 ml of a chemically defined medium at pH 7, consisting of 1.5 glycerol , 2% sucrose, 0.25 % proline, 0.15 % sodium glutamate, 0.5 % NaCl, 0.2 % K2HPO4, 0.04 % CaCl2 , 0.01 MnCl2.4H2O, 0.01 % FeCl3.6H2O, 0.005 % ZnCl2, 0.1 % MgSO3.7H2O in deionised water. Ten ml of the seed culture were transferred after 4 days to each of a series of 2-liter flasks containing 500 ml of the same medium. The flasks were incubated at 26°C on a rotary shaker (240 rpm, 5-cm throw) for 72 hours. Three active metabolites were detected in the culture broth by biochromatography , of MM 21801 was only detected in culture broths of the IT1 mutant of Sireptom}ices clavuligerus, and was not observed to be a metabolite of the parent strain. Three of the /3-lactam antibiotics which have been reported to be produced by S. clavuligerus, penicillin N, deacetoxycephalosporin C and the 3-carbamoyloxymethyl analogue of cephalosporin C, were not detected in the fermentation broths of either the mutant strain or the parent culture, when grown under the conditions described above.
Physical Properties
The crystalline preparation of MM 21801 was identified as the antibiotic holomycin (Fig. 2a) An agar slope culture of the Streptomyces clavuligerus mutant ITI was also used to inoculate 50O-m1 flasks containing 100 ml of a seed medium consisting of I % malt extract (Oxoid), 1%
bacteriological peptone (Oxoid) and 2 % glycerol, in tap water (pH adjusted to 7.0 prior to sterilisation).
Fifteen ml of the seed culture were transferred after 4 days to each of a series of 2-liter flasks containing 500 ml of production medium consisting of 1.0% triglyceride (Prichem P224, Prices Ltd., Bromborough, Bebington, Cheshire, U.K.), 1.5%, soya bean flour (Arkasoy 50, British Arkady Co. Ltd., Old Trafford, Manchester, U.K.) and 0.1 % KH2POa, in deionised water (pH adjusted to 7.0 prior to sterilisation). The flasks were incubated at 26°C on a rotary shaker (240 rpm, 5-cm throw) for 92 hours. Four active metabolites were detected in the culture broth by biochromatography. These were clavulanic acid, cephamycin C, penicillin N, and a lipophilic antibiotic, which was separated by paper chromatography from the other metabolites of Streptomyces clavuligerus and was designated MM 19290 (Table 1 ). This substance inhibited the growth of Bacillus subtilis, but had no activity against Gram-negative organisms. It was stable to the /3-lactamase of E. coli JT4. The antibiotic MM 19290 was isolated from 6 liters of the culture broth by the procedure outlined in Fig. 3 . Minutes Minutes preparations had the same chromatographic mobility on thin-layer plates and paper in several solvent systems. MM 19290 was also compared directly with tunicamycin by h.p.l.c. (Fig. 4) . Both samples gave four corresponding groups of peaks with identical retention times (groups III, IV, V and VI, Fig. 4) . However, the MM 19290 preparation gave two additional peaks (I and II, Fig. 4 ) of significant intensity, closer to the solvent front, which were not clearly visible when tunicamycin was chromatographed under the same conditions. In order to determine whether the components responsible for these peaks had antibacterial activity, a separate fraction was collected from the h.p.l.c. column for each of the peaks, or groups of peaks, I -VI, produced by the sample of MM 19290 (Fig. 4) . When analysed by biochromatography on paper, all six fractions gave zones of inhibition in the position of MM 19290, suggesting that the preparation of MM 19290 was a complex containing at least six related antibiotics.
Discussion
Holomycin is a member of the pyrrothine group of antibiotics and was originally described as a metabolit3 of Streptomyces griseust0). Subsequent to our isolation of the antibiotic from Streptomyces clavuligerus, OKAMURA et al.11) reported that holomycin and N-propionylholothin ( on t.l.c. plates (Merck silica gel 60) in addition to holomycin ( Table 2 ). This may indicate the production of other members of the pyrrothine group of antibiotics by Streptomyces clavuligerus.
Tunicamycin is a member of the group of streptomycete antibiotics which includes mycospocidin,13> antibiotic 24010,14) and the streptovirudins of series II,15) and is reported to be an inhibitor of peptidoglycan synthesis. 16) After the present work had been completed, the structure of tunicamycin (Fig. 5 ) was published by TAKATSUKI et al. 17 ) Tunicamycin was shown to be a mixture of four homologous antibiotics which differ in the length of the carbon chain of the trans a,/3-unsaturated iso-fatty acid component (where n=8, 9, 10 or 11). The four common groups of peaks (III-VI, Fig. 4 ) which are observed after h.p.l.c. of both the preparations of tunicamycin and MM 19290, may therefore be due in part to the four components of the tunicamycin complex which have been described by TAKATSUKI et al. The chromatogram of tunicamycin shows a number of peaks grouped in pairs, or in the case of group IV (Fig. 4) , a main peak with two shoulders, and may indicate that the antibiotic complex consists of more than the four components reported by TAKATSUKI. These extra components may represent isomeric forms. In addition, it would appear that the two peaks with lowest retention time, I and 11, observed with MM 19290, which are absent from the h.p.l. chromatogram of the sample of authentic tunicamycin, are due to further, as yet uncharacterised homologous antibiotics with different fatty acid side chains. The relative intensities of the corresponding peaks observed with both the MM 19290 and tunicamycin samples are also different, which suggests that the common components are not present in the same proportions in the two preparations.
The h.p.l.c. studies have shown therefore that in these respects, the MM 19290 complex isolated from S. clavuligerus differs from the tunicamycin complex (ex. S. lysosuperificus).
